Search

Kevin S. Orwig

Examiner (ID: 15505, Phone: (571)270-5869 , Office: P/1611 )

Most Active Art Unit
1611
Art Unit(s)
3991, 1658, 1611
Total Applications
910
Issued Applications
256
Pending Applications
48
Abandoned Applications
609

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17695875 [patent_doc_number] => 11369576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-28 [patent_title] => Transdermal patch with separated regions for delivery of immunomodulators [patent_app_type] => utility [patent_app_number] => 15/865001 [patent_app_country] => US [patent_app_date] => 2018-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 57 [patent_no_of_words] => 22194 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 408 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15865001 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/865001
Transdermal patch with separated regions for delivery of immunomodulators Jan 7, 2018 Issued
Array ( [id] => 14596823 [patent_doc_number] => 10351594 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-16 [patent_title] => Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging [patent_app_type] => utility [patent_app_number] => 15/861300 [patent_app_country] => US [patent_app_date] => 2018-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 18249 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861300 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/861300
Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging Jan 2, 2018 Issued
Array ( [id] => 12675676 [patent_doc_number] => 20180117058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-03 [patent_title] => SKIN-PENETRATING FORMULATION OF TAUROLIDINE [patent_app_type] => utility [patent_app_number] => 15/858228 [patent_app_country] => US [patent_app_date] => 2017-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5463 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15858228 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/858228
SKIN-PENETRATING FORMULATION OF TAUROLIDINE Dec 28, 2017 Abandoned
Array ( [id] => 15766045 [patent_doc_number] => 20200114040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => ANTIMICROBIAL WOUND DRESSINGS [patent_app_type] => utility [patent_app_number] => 16/472144 [patent_app_country] => US [patent_app_date] => 2017-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6358 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472144 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/472144
ANTIMICROBIAL WOUND DRESSINGS Dec 27, 2017 Abandoned
Array ( [id] => 13440615 [patent_doc_number] => 20180271850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => ASSAYS, METHODS AND MEANS [patent_app_type] => utility [patent_app_number] => 15/853103 [patent_app_country] => US [patent_app_date] => 2017-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53664 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853103 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/853103
ASSAYS, METHODS AND MEANS Dec 21, 2017 Abandoned
Array ( [id] => 16175540 [patent_doc_number] => 20200222508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONIST COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/471596 [patent_app_country] => US [patent_app_date] => 2017-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10093 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471596 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/471596
GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONIST COMPOSITIONS Dec 21, 2017 Abandoned
Array ( [id] => 13440617 [patent_doc_number] => 20180271851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => ASSAYS, METHODS AND MEANS [patent_app_type] => utility [patent_app_number] => 15/853174 [patent_app_country] => US [patent_app_date] => 2017-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53664 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853174 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/853174
ASSAYS, METHODS AND MEANS Dec 21, 2017 Abandoned
Array ( [id] => 15114513 [patent_doc_number] => 20190343889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-14 [patent_title] => A METHOD FOR DRYING CELL-FREE TISSUE EXTRACT IN A HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND A DRIED HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND CELL-FREE TISSUE EXTRACT [patent_app_type] => utility [patent_app_number] => 16/466772 [patent_app_country] => US [patent_app_date] => 2017-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16466772 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/466772
A METHOD FOR DRYING CELL-FREE TISSUE EXTRACT IN A HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND A DRIED HYDROGEL COMPRISING NANOFIBRILLAR CELLULOSE AND CELL-FREE TISSUE EXTRACT Dec 14, 2017 Abandoned
Array ( [id] => 12606594 [patent_doc_number] => 20180094028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => ACTIVE PEPTIDE FOR INHIBITING AMPA RECEPTOR AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/834026 [patent_app_country] => US [patent_app_date] => 2017-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15834026 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/834026
Active peptide for inhibiting AMPA receptor and preparation method and use thereof Dec 5, 2017 Issued
Array ( [id] => 12904711 [patent_doc_number] => 20180193412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-12 [patent_title] => Method of In Vivo Treatment [patent_app_type] => utility [patent_app_number] => 15/833171 [patent_app_country] => US [patent_app_date] => 2017-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15833171 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/833171
Method of In Vivo Treatment Dec 5, 2017 Abandoned
Array ( [id] => 13457779 [patent_doc_number] => 20180280432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => METHODS OF TREATING IRON DEFICIENCY WITH SOLUBLE FERRIC PYROPHOSPHATE [patent_app_type] => utility [patent_app_number] => 15/809734 [patent_app_country] => US [patent_app_date] => 2017-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809734 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/809734
METHODS OF TREATING IRON DEFICIENCY WITH SOLUBLE FERRIC PYROPHOSPHATE Nov 9, 2017 Abandoned
Array ( [id] => 12233152 [patent_doc_number] => 20180066016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'Pharmaceutical Compositions and Therapeutic Methods of Use Comprising Selective Agonists of Melanocortin 1 Receptor' [patent_app_type] => utility [patent_app_number] => 15/794301 [patent_app_country] => US [patent_app_date] => 2017-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11314 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15794301 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/794301
Method of using pharmaceutical compositions comprising selective peptide-based agonists of melanocortin 1 receptor Oct 25, 2017 Issued
Array ( [id] => 14649157 [patent_doc_number] => 20190231707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => TRANSDERMAL DRUG DELIVERY DEVICE FOR DELIVERING OPIOIDS [patent_app_type] => utility [patent_app_number] => 16/330111 [patent_app_country] => US [patent_app_date] => 2017-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17994 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330111 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/330111
TRANSDERMAL DRUG DELIVERY DEVICE FOR DELIVERING OPIOIDS Sep 27, 2017 Abandoned
Array ( [id] => 14435287 [patent_doc_number] => 20190175515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => CHOLESTERYL ESTER VESICLES LOADING PEPTIDES, PROTEINS AND NUCLEIC ACIDS INTO CHYLOMICRONS AND BODY CELLS [patent_app_type] => utility [patent_app_number] => 16/327561 [patent_app_country] => US [patent_app_date] => 2017-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48585 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327561 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/327561
CHOLESTERYL ESTER VESICLES LOADING PEPTIDES, PROTEINS AND NUCLEIC ACIDS INTO CHYLOMICRONS AND BODY CELLS Aug 22, 2017 Abandoned
Array ( [id] => 18517608 [patent_doc_number] => 11707478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Method for increasing uridine concentration in blood plasma [patent_app_type] => utility [patent_app_number] => 16/327741 [patent_app_country] => US [patent_app_date] => 2017-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10471 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16327741 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/327741
Method for increasing uridine concentration in blood plasma Aug 22, 2017 Issued
Array ( [id] => 13714471 [patent_doc_number] => 20170368190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-28 [patent_title] => Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same [patent_app_type] => utility [patent_app_number] => 15/672802 [patent_app_country] => US [patent_app_date] => 2017-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15672802 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/672802
Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same Aug 8, 2017 Issued
Array ( [id] => 12975841 [patent_doc_number] => 20170340697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/667737 [patent_app_country] => US [patent_app_date] => 2017-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15667737 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/667737
Selective Nox-1 inhibitor peptides and uses thereof Aug 2, 2017 Issued
Array ( [id] => 14403999 [patent_doc_number] => 20190167843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => NERVE GUIDANCE CONDUITS, METHODS OF PRODUCTION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/322253 [patent_app_country] => US [patent_app_date] => 2017-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6076 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322253 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/322253
NERVE GUIDANCE CONDUITS, METHODS OF PRODUCTION AND USES THEREOF Jul 31, 2017 Abandoned
Array ( [id] => 12232102 [patent_doc_number] => 20180064965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-08 [patent_title] => 'PEPTIDE FOR PROMOTING HAIR GROWTH' [patent_app_type] => utility [patent_app_number] => 15/615211 [patent_app_country] => US [patent_app_date] => 2017-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 1706 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615211 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/615211
Peptide for promoting hair growth Jun 5, 2017 Issued
Array ( [id] => 13311513 [patent_doc_number] => 20180207293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 15/604361 [patent_app_country] => US [patent_app_date] => 2017-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604361 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/604361
NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE May 23, 2017 Abandoned
Menu